| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLD | Audentes Therapeutics, Inc. | NEWMAN MARY | SVP, Regulatory Affairs | Nov 15, 2018 | Option Exercise | $19.64 | 660 | 12,959 | 660 | Nov 16, 2018, 06:41 PM | |
| BOLD | Audentes Therapeutics, Inc. | NEWMAN MARY | SVP, Regulatory Affairs | Jun 25, 2018 | Sale | $21.49 | 17,090 | 367,254 | 8,245 | Jun 27, 2018, 06:52 PM | |
| BOLD | Audentes Therapeutics, Inc. | NEWMAN MARY | SVP, Regulatory Affairs | Mar 15, 2018 | Sale | $16.28 | 20,000 | 325,527 | 5,524 | Apr 02, 2018, 09:06 PM | |
| BOLD | Audentes Therapeutics, Inc. | NEWMAN MARY | SVP, Regulatory Affairs | Nov 16, 2017 | Sale | $14.51 | 20,000 | 290,275 | 5,740 | Nov 17, 2017, 05:06 PM | |
| BOLD | Audentes Therapeutics, Inc. | NEWMAN MARY | SVP, Regulatory Affairs | Aug 24, 2017 | Option Exercise | $11.10 | 20,000 | 221,900 | 10,000 | Aug 25, 2017, 04:17 PM |
Menu